Skip to content

Trios - M

by Biotronik Sales, Inc. 510(k)

Active United States

510(k) K853057

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK853057 Date12 Sep 1985ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The TRIOS-M is an Implantable Pacemaker Pulse-Generator, designed to regulate cardiac rhythm by delivering electrical impulses to the heart when spontaneous contractions are insufficient. It is intended for patients requiring single-chamber pacing, providing consistent pacing stimuli to maintain proper heart function in conditions such as sinus node dysfunction or bradycardia.

This device is implanted subcutaneously in the chest, typically under local or general anesthesia, and is intended for long-term use. Supplied sterile and intended for single-patient use, it must be handled in a controlled environment to maintain sterility. The TRIOS-M complies with FDA 510(k) clearance under classification DXY and regulation 870.3610, with multiple registration numbers recorded in the OpenFDA database. It is not MRI-safe and requires proper shielding during imaging procedures.

Other devices from Biotronik Sales, Inc.

See all devices from Biotronik Sales, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of patients is the TRIOS-M pacemaker designed to treat, and how does it work?

    The TRIOS-M is designed for patients with single-chamber pacing needs, such as those experiencing sinus node dysfunction or bradycardia, where the heart’s natural rhythm is insufficient. It regulates cardiac rhythm by delivering electrical impulses to the heart when spontaneous contractions are too slow or irregular, ensuring consistent pacing to maintain proper heart function. The device is implanted subcutaneously in the chest and operates as a long-term solution.

  • Is the TRIOS-M pacemaker intended for reuse, or is it single-use only?

    The TRIOS-M is sterile and intended for single-patient use only. It must be handled in a controlled environment to preserve sterility, as it is not designed for reuse or reprocessing. This ensures patient safety and compliance with medical device standards.

  • What precautions should be taken when a patient with a TRIOS-M pacemaker undergoes MRI imaging?

    The TRIOS-M is not MRI-safe, meaning it should not be exposed to MRI procedures without proper shielding. Patients with this device must avoid MRI scans unless specifically approved with appropriate protective measures, as the electromagnetic fields could interfere with the pacemaker’s function or cause damage.

  • How is the TRIOS-M pacemaker supplied, and what should be considered during storage?

    The TRIOS-M is supplied sterile and ready for implantation, requiring careful handling to maintain sterility. Since it is intended for single-patient use, it should be stored in its original packaging in a clean, dry environment, away from direct sunlight or extreme temperatures, until immediate use. Proper storage ensures the device remains functional and uncontaminated.